Analyze your cancer program’s current market performance and identify future opportunities.
The Center for Advanced Oncology has designed OncoINTEL Assessment to help cancer organizations generate and use detailed analytics to better serve cancer patients and manage the broader oncology service line. OncoINTEL Analytics is an assessment tool that measures your cancer program’s performance and capabilities against the local market and helps organizations prioritize efforts to increase access, improve patient care, and advance service offerings.
Actionable Insights
OncoINTEL Assessment uses proprietary modeling to provide your cancer program with a detailed, quantitative analysis to better understand your market and performance within it. Your customized report will include elements such as your program’s cancer case volume trends, market share by tumor site, out-migration and leakage, and patient origin.
How it Works
OncoINTEL Assessment reporting includes insights based on three core analyses:
- Volume Trends: Retrospective cancer registry volume and distribution trends by tumor site, histology (tumor type/behavior), and patient origin
- Market Sizing: Retrospective distribution of new cancer cases in the market and prospective analysis of market growth and future case distribution
- Market Share: Retrospective capture of new cancer cases by tumor site and geographic unit (by zip code or county level)
Package Pricing
Depending on your organization’s needs and desired level of detail, ECG offers two OncoINTEL Analytics reporting packages.
Additional Options
Additional reporting options can be added to your package:
- Drive-time mapping
- Market share by modality (“share of care” analysis)
- Clinical service volumes
- Physician demand
- Growth projections
- Resources, equipment, and facility sizing
- Financial performance
Published September 12, 2023
